New eyes on the infectious disease prize

IF 122.7 1区医学 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Nature Reviews. Drug Discovery Pub Date : 2024-10-15 DOI:10.1038/d41573-024-00169-2

Asher Mullard

引用次数: 0

Abstract

Jeanne Marrazzo, the director of the NIAID, discusses post-COVID pandemic preparedness, H5N1 avian flu and the tension between infectious disease protection versus profit. Jeanne Marrazzo, the director of the NIAID, discusses post-COVID pandemic preparedness, H5N1 avian flu and the tension between infectious disease protection versus profit.

Abstract Image

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

传染病奖的新视角

美国国立卫生研究院（NIAID）院长珍妮-马拉佐（Jeanne Marrazzo）讨论了后 COVID 大流行准备工作、H5N1 禽流感以及传染病保护与利润之间的矛盾。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Nature Reviews. Drug Discovery 医学-生物工程与应用微生物

CiteScore

137.40

自引率

0.30%

发文量

227

期刊介绍： Nature Reviews Drug Discovery is a monthly journal aimed at everyone working in the drug discovery and development arena. Each issue includes: Highest-quality reviews and perspectives covering a broad scope. News stories investigating the hottest topics in drug discovery. Timely summaries of key primary research papers. Concise updates on the latest advances in areas such as new drug approvals, patent law, and emerging industry trends and strategies.

期刊最新文献

New eyes on the infectious disease prize Protein degraders push into novel target space FDA new drug approvals in Q3 2024 Tumour cells get a dendritic cell makeover mRNA vaccines for infectious diseases — advances, challenges and opportunities